Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aimei Health Technology (AFJK) Net Income towards Common Stockholders (2024 - 2025)

Aimei Health Technology (AFJK) has 2 years of Net Income towards Common Stockholders data on record, last reported at $352019.0 in Q3 2025.

  • On a quarterly basis, Net Income towards Common Stockholders fell 52.65% to $352019.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.4 million, a 33.32% decrease, with the full-year FY2024 number at $2.6 million, up 1389.14% from a year prior.
  • Net Income towards Common Stockholders reached $352019.0 in Q3 2025 per AFJK's latest filing, down from $424970.0 in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for AFJK hit a ceiling of $755500.0 in Q1 2024 and a floor of $184662.0 in Q1 2025.